Novan Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
7,419.00
45,688.00
34,611.00
2,524.00
8,194
Other Current Assets
575.00
936.00
958.00
883.00
1,107
Total Current Assets
7,994.00
46,624.00
35,569.00
3,407.00
9,301
Net Property, Plant & Equipment
1,918.00
2,344.00
16,290.00
16,624.00
15,868
Total Investments and Advances
-
539.00
539.00
539.00
539
Intangible Assets
-
-
75.00
75.00
75
Other Assets
15.00
309.00
-
489.00
579
Total Assets
9,927.00
49,816.00
52,473.00
21,134.00
26,362
ST Debt & Current Portion LT Debt
6.00
6.00
10.00
11.00
Accounts Payable
947.00
1,626.00
-
479.00
Other Current Liabilities
814.00
3,463.00
13,367.00
7,928.00
Total Current Liabilities
1,767.00
5,095.00
13,377.00
8,418.00
Long-Term Debt
10.00
4.00
8,030.00
8,019.00
Other Liabilities
-
-
-
6,919.00
Total Liabilities
1,777.00
5,099.00
21,407.00
23,356.00
Common Equity (Total)
29,549.00
60,081.00
31,066.00
2,222.00
Total Shareholders' Equity
8,150.00
44,717.00
31,066.00
2,222.00
Total Equity
8,150.00
44,717.00
31,066.00
2,222.00
Liabilities & Shareholders' Equity
9,927.00
49,816.00
52,473.00
21,134.00
Preferred Stock (Carrying Value)
37,699.00
104,798.00
-
-

About Novan

View Profile
Address
4105 Hopson Road
Morrisville North Carolina 27560
United States
Employees -
Website http://www.novan.com
Updated 07/08/2019
Novan, Inc. is a biotechnology company which uses nitric oxide-based technology to develop product candidates. It focuses on nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.